Genetics & Epigenetics of Aging

This feed focuses on the genetics and epigenetics of aging. Discover the latest research here.

October 13, 2020

Investigation of accelerated epigenetic aging in individuals experiencing suicidal ideation

Schizophrenia Research
Oluwagbenga DadaVincenzo De Luca
October 9, 2020

Induced pluripotent stem cell reprogramming-associated methylation at the GABRA2 promoter and chr4p12 GABAA subunit gene expression in the context of alcohol use disorder

American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics
Alexandra GoetjenJonathan Covault
October 24, 2020

Genetics of facial telangiectasia in the Rotterdam Study: a genome-wide association study and candidate gene approach

Journal of the European Academy of Dermatology and Venereology : JEADV
S MekićL M Pardo
October 9, 2020
Review

Epigenetic memory: gene writer, eraser and homocysteine

Molecular and Cellular Biochemistry
Suresh C TyagiMahavir Singh
October 21, 2020
Review

Vitamin D and its Effects on DNA Methylation in Development, Aging and Disease

Molecular Nutrition & Food Research
Lawrence T C OngGrant P Parnell
October 13, 2020
Review
Open Access

Eating Disorders During Gestation: Implications for Mother's Health, Fetal Outcomes, and Epigenetic Changes

Frontiers in Pediatrics
Giorgia SebastianiOscar García-Algar
October 13, 2020
Open Access

ELOVL2: Not just a biomarker of aging

Translational Medicine of Aging
Daniel L Chao, Dorota Skowronska-Krawczyk
October 24, 2020

Klotho, PTSD, and advanced epigenetic age in cortical tissue

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Erika J WolfMark W Logue
October 11, 2020
Open Access

SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia

Oncogene
Yajing ChuWeiping Yuan
October 20, 2020
Preprint
Open Access

A phenome-wide multi-directional Mendelian randomization analysis of atrial fibrillation

MedRxiv : the Preprint Server for Health Sciences
Qin WangM. Holmes
October 13, 2020

Olmesartan alleviates bleomycin-mediated vascular smooth muscle cell senescence via the miR-665/SDC1 axis

American Journal of Translational Research
Yi ZhangLi Zhang
October 24, 2020
Review

Oligodendrocyte progenitors as environmental biosensors

Seminars in Cell & Developmental Biology
David K DansuPatrizia Casaccia
October 21, 2020
Open Access

Methylation-dependent antioxidant-redox imbalance regulates hypertensive kidney injury in aging

Redox Biology
Sathnur PushpakumarUtpal Sen

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) share a considerable proportion of characteristics including the same neuropathological substrate of abnormally phosphorylated TAR DNA binding protein (TDP-43). Here are the latest discoveries pertaining to ALS, FTD and TDP-43.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS - Stress Granules

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

© 2020 Meta ULC. All rights reserved
/feed-previews/aging-genetics/e34dae28-435e-4d46-9b75-24de07d6bf4b